Bevacizumab for the Treatment of Glioblastoma by Miguel J. Gil-Gil, Carlos Mesia, Montserrat Rey, Jordi Bruna

Get full text

Bevacizumab for the Treatment of Glioblastoma by Miguel J. Gil-Gil, Carlos Mesia, Montserrat Rey, Jordi Bruna

Get full text

Depositional sequences and ammonoid assemblages in the upper Cenomanian-lower Santonian of the Iberian Peninsula (Spain and Portugal) by M. SEGURA, F. BARROSO-BARCENILLA, P. CALLAPEZ, J.F. GARCÍA-HIDALGO, J. GIL-GIL

Get full text

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. by David Molina, Julián Pérez-Beteta, Alicia Martínez-González, Juan M Sepúlveda, Sergi Peralta, Miguel J Gil-Gil, Gaspar Reynes, Ana Herrero, Ramón De Las Peñas, Raquel Luque, Jaume Capellades, Carmen Balaña, Víctor M Pérez-García

Get full text

Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study by David Mills, Hui Gan, Jeffrey Raizer, Patrick Yung Wen, Warren Mason, John DeGroot, Valerie Donnet, Mona El-Hashimy, Mark Rosenthal, Paul M Clement, Mario Campone, Miguel J Gil-Gil, Olivier Chinot, Ahmed Idbaih, Estela Pineda

Get full text

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Fina... by Miguel J. Gil-Gil, Meritxell Bellet, Milana Bergamino, Serafín Morales, Agustí Barnadas, Luís Manso, Cristina Saura, Adela Fernández-Ortega, Elena Garcia-Martinez, Noelia Martinez-Jañez, Mireia Melé, Patricia Villagrasa, Pamela Celiz, X. Perez Martin, Eva Ciruelos, Sonia Pernas

Get full text